KIF11, known as mitotic spindle-specific protein, and its oral inhibitor 4SC-205 demonstrates anti-tumor activity and enhances targeted therapy in primary and metastatic neuroblastoma models (Masanas et al., 2021). The gene discussed is KIF11; the disease is neoplasm.